Tatiana Wiktorowicz
Overview
Explore the profile of Tatiana Wiktorowicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016-19)
Canton R, Hamed K, Wiktorowicz T, Redder N, Jemmely N, Quevedo J, et al.
JAC Antimicrob Resist
. 2022 Mar;
4(2):dlac030.
PMID: 35350131
Objectives: To evaluate the susceptibility to ceftobiprole of clinical bacterial isolates obtained from hospitalized patients in Europe. Methods: A total of 20 000 non-duplicate bacterial isolates were collected in 2016-19...
2.
Hamed K, Wiktorowicz T, Assadi Gehr M
Infect Drug Resist
. 2020 Sep;
13:3209-3215.
PMID: 32982335
Purpose: Drug-induced immune hemolytic anemia (DIIHA) is a rare but serious adverse event associated with a number of drugs, including second- and third-generation cephalosporins. A positive direct antiglobulin test (DAT)...
3.
Hawser S, Kothari N, Karlowsky J, Wiktorowicz T, Hamed K
Diagn Microbiol Infect Dis
. 2020 Jan;
96(4):114978.
PMID: 31952866
Ceftobiprole was active (MIC, ≤2 mg/L) against most isolates (99.7%; 877/880) of methicillin-resistant Staphylococcus aureus from respiratory tract infections collected in 14 European countries during 2016-2017. Whole-genome sequence analysis showed...
4.
Pea F, Krause R, Muller C, Hennart B, Richardson M, Meinitzer A, et al.
Ther Drug Monit
. 2019 Oct;
41(5):657-664.
PMID: 31568234
Background: Under certain circumstances, clinicians treating patients with isavuconazole for invasive aspergillosis or mucormycosis may use therapeutic drug monitoring. However, the accuracy and reproducibility of the various assays used by...
5.
Counsell J, Karda R, Diaz J, Carey L, Wiktorowicz T, Buckley S, et al.
Mol Ther Nucleic Acids
. 2018 Aug;
12:626-634.
PMID: 30081233
Viral vectors are rapidly being developed for a range of applications in research and gene therapy. Prototype foamy virus (PFV) vectors have been described for gene therapy, although their use...
6.
Brockhoff M, Rion N, Chojnowska K, Wiktorowicz T, Eickhorst C, Erne B, et al.
J Clin Invest
. 2017 Jan;
127(2):549-563.
PMID: 28067669
Myotonic dystrophy type I (DM1) is a disabling multisystemic disease that predominantly affects skeletal muscle. It is caused by expanded CTG repeats in the 3'-UTR of the dystrophia myotonica protein...
7.
Herrendorff R, Faleschini M, Stiefvater A, Erne B, Wiktorowicz T, Kern F, et al.
J Biol Chem
. 2016 Jun;
291(33):17165-77.
PMID: 27298317
Myotonic dystrophy type I (DM1) is a disabling neuromuscular disease with no causal treatment available. This disease is caused by expanded CTG trinucleotide repeats in the 3' UTR of the...
8.
Wiktorowicz T, Kinter J, Kobuke K, Campbell K, Sinnreich M
Skelet Muscle
. 2015 Oct;
5:32.
PMID: 26464793
Background: Mouse models of dysferlinopathies are valuable tools with which to investigate the pathomechanisms underlying these diseases and to test novel therapeutic strategies. One such mouse model is the Dysf...
9.
Plochmann K, Horn A, Gschmack E, Armbruster N, Krieg J, Wiktorowicz T, et al.
J Virol
. 2012 Jul;
86(18):10028-35.
PMID: 22787203
The cellular receptor of foamy viruses (FVs) is unknown. The broad spectrum of permissive cells suggests that the cellular receptor is a molecular structure with almost ubiquitous prevalence. Here, we...
10.
Matthes D, Wiktorowicz T, Zahn J, Bodem J, Stanke N, Lindemann D, et al.
J Virol
. 2011 Feb;
85(8):3986-95.
PMID: 21289113
Foamy virus (FV) capsid proteins have few lysines. Basic residues are almost exclusively represented by arginines indicating positive selective pressure. To analyze the possible functions of this peculiarity, we mutated...